Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-May-2013
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 6 of 6)
Release
Date [down]		 Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
23-May-13ValuEngine, Inc.N/AValuEngine Industry Report for Medical Instruments17$195.50  View Abstract
23-May-13Wright ReportsN/AWright Investors Service Comprehensive Report for Pressure Biosciences, Inc.41$471.50  View Abstract
17-May-13Reuters Investment ProfileN/APressure Biosciences Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138  View Abstract
16-May-13ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for PBIO11$126.50  View Abstract
11-May-13S&P Capital IQ Quantitative ReportN/APressure BioSciences6$69  View Abstract
4-Apr-13Streetwise ReportsN/A6 Biotechs with Staggering Potential: Grant Zeng12$115  View Abstract
Independent Reports (Showing 1 to 6 of 6)
Release
Date [down]		 Contributor Author Title Pages Price More Info
23-May-13ValuEngine, Inc.N/AValuEngine Industry Report for Medical Instruments17$195.50View Abstract
23-May-13Wright ReportsN/AWright Investors Service Comprehensive Report for Pressure Biosciences, Inc.41$471.50View Abstract
17-May-13Reuters Investment ProfileN/APressure Biosciences Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138View Abstract
16-May-13ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for PBIO11$126.50View Abstract
11-May-13S&P Capital IQ Quantitative ReportN/APressure BioSciences6$69View Abstract
4-Apr-13Streetwise ReportsN/A6 Biotechs with Staggering Potential: Grant Zeng12$115View Abstract

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.